Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluate the Persistence of Immune Response of GSK Biologicals' Twinrix Vaccine, Administered According to a 0,6 m Schedule and a 0,1,6 m Schedule, in Healthy Children Aged Between 1-11 y at the Time of First Vaccine Dose

Next Previous
X
Search
Trial Profile

Evaluate the Persistence of Immune Response of GSK Biologicals' Twinrix Vaccine, Administered According to a 0,6 m Schedule and a 0,1,6 m Schedule, in Healthy Children Aged Between 1-11 y at the Time of First Vaccine Dose

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hepatitis A-hepatitis B vaccine (Primary)
  • Indications Hepatitis A; Hepatitis B
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline; GSK

    • Most Recent Events

    • 28 Apr 2010 Five-year follow-up results published in Vaccine.
    • 06 Nov 2008 New source identified and integrated (ClinicalTrials.gov record NCT00787449).
    • 12 Aug 2008 Actual patient number added (276) as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top